title: Reply to R.C. Turkington et al.
authors: St Thomas' Hospital, London, United Kingdom andrew.davies1@gstt.nhs.uk.
authors: Andrew R
authors: AR
authors: Davies
authors: St Thomas' Hospital, London, United Kingdom.
authors: James A
authors: JA
authors: Gossage
authors: King's College London, London, United Kingdom.
authors: Janine L
authors: JL
authors: Zylstra
authors: Karolinska Institutet, Solna, Sweden.
authors: Fredrik
authors: F
authors: Mattsson
authors: Karolinska Institutet, Solna, Sweden.
authors: Jesper
authors: J
authors: Lagergren
authors: St Thomas' Hospital, London, United Kingdom.
authors: Nick
authors: N
authors: Maisey
authors: Royal Marsden Hospital, London, United Kingdom.
authors: Elizabeth C
authors: EC
authors: Smyth
authors: Royal Marsden Hospital, London, United Kingdom.
authors: David
authors: D
authors: Cunningham
authors: Royal Marsden Hospital, London, United Kingdom.
authors: William H
authors: WH
authors: Allum
authors: St Thomas' Hospital, London, United Kingdom.
authors: Robert C
authors: RC
authors: Mason
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality* / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000401:mortality* / Q000473:pathology*; D004943:Esophagogastric Junction; D005260:Female; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy / Q000379:methods*; D013274:Stomach Neoplasms / Q000401:mortality* / Q000473:pathology*